PARP-1 activation causes neuronal death in the hippocampal CA1 region by increasing the expression of Ca(2+)-permeable AMPA receptors
- PMID: 24954469
- DOI: 10.1016/j.nbd.2014.05.023
PARP-1 activation causes neuronal death in the hippocampal CA1 region by increasing the expression of Ca(2+)-permeable AMPA receptors
Abstract
An excessive activation of poly(ADP-ribose) polymerases (PARPs) may trigger a form of neuronal death similar to that occurring in neurodegenerative disorders. To investigate this process, we exposed organotypic hippocampal slices to N-methyl-N'-nitro-N'-nitrosoguanidine (MNNG, 100μM for 5min), an alkylating agent widely used to activate PARP-1. MNNG induced a pattern of degeneration of the CA1 pyramidal cells morphologically similar to that observed after a brief period of oxygen and glucose deprivation (OGD). MNNG exposure was also associated with a dramatic increase in PARP-activity and a robust decrease in NAD(+) and ATP content. These effects were prevented by PARP-1 but not PARP-2 inhibitors. In our experimental conditions, cell death was not mediated by AIF translocation (parthanatos) or caspase-dependent apoptotic processes. Furthermore, we found that PARP activation was followed by a significant deterioration of neuronal membrane properties. Using electrophysiological recordings we firstly investigated the suggested ability of ADP-ribose to open TRPM2 channels in MNNG-induced cells death, but the results we obtained showed that TRPM2 channels are not involved. We then studied the involvement of glutamate receptor-ion channel complex and we found that NBQX, a selective AMPA receptor antagonist, was able to effectively prevent CA1 neuronal loss while MK801, a NMDA antagonist, was not active. Moreover, we observed that MNNG treatment increased the ratio of GluA1/GluA2 AMPAR subunit expression, which was associated with an inward rectification of the IV relationship of AMPA sEPSCs in the CA1 but not in the CA3 subfield. Accordingly, 1-naphthyl acetyl spermine (NASPM), a selective blocker of Ca(2+)-permeable GluA2-lacking AMPA receptors, reduced MNNG-induced CA1 pyramidal cell death. In conclusion, our results show that activation of the nuclear enzyme PARP-1 may change the expression of membrane proteins and Ca(2+) permeability of AMPA channels, thus affecting the function and survival of CA1 pyramidal cells.
Keywords: Ca(2+)-permeable AMPA receptors; Cell death; GluA1; Hippocampus; MNNG; Organotypic hippocampal slices; PARP.
Copyright © 2014 Elsevier Inc. All rights reserved.
Similar articles
-
Poly(ADP-Ribose)Polymerase 1 (PARP-1) Activation and Ca(2+) Permeable α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid (AMPA) Channels in Post-Ischemic Brain Damage: New Therapeutic Opportunities?CNS Neurol Disord Drug Targets. 2015;14(5):636-46. doi: 10.2174/1871527314666150430162841. CNS Neurol Disord Drug Targets. 2015. PMID: 25924998 Review.
-
Mild activation of poly(ADP-ribose) polymerase (PARP) is neuroprotective in rat hippocampal slice models of ischemic tolerance.Eur J Neurosci. 2012 Jul;36(1):1993-2005. doi: 10.1111/j.1460-9568.2012.08116.x. Epub 2012 May 28. Eur J Neurosci. 2012. PMID: 22639866
-
Poly(ADP-ribose) polymerase inhibitors attenuate necrotic but not apoptotic neuronal death in experimental models of cerebral ischemia.Cell Death Differ. 2001 Sep;8(9):921-32. doi: 10.1038/sj.cdd.4400884. Cell Death Differ. 2001. PMID: 11526447
-
Acid-sensing ion channel 1a drives AMPA receptor plasticity following ischaemia and acidosis in hippocampal CA1 neurons.J Physiol. 2015 Oct 1;593(19):4373-86. doi: 10.1113/JP270701. Epub 2015 Aug 18. J Physiol. 2015. PMID: 26174503 Free PMC article.
-
Poly (adp-ribose) polymerase inhibitors as potential therapeutic agents in stroke and neurotrauma.Curr Drug Targets CNS Neurol Disord. 2005 Apr;4(2):179-94. doi: 10.2174/1568007053544138. Curr Drug Targets CNS Neurol Disord. 2005. PMID: 15857303 Review.
Cited by
-
Sevoflurane-induced memory impairment in the postnatal developing mouse brain.Exp Ther Med. 2018 May;15(5):4097-4104. doi: 10.3892/etm.2018.5950. Epub 2018 Mar 12. Exp Ther Med. 2018. PMID: 29731813 Free PMC article.
-
Emerging role of PARP-1 and PARthanatos in ischemic stroke.J Neurochem. 2022 Jan;160(1):74-87. doi: 10.1111/jnc.15464. Epub 2021 Jul 28. J Neurochem. 2022. PMID: 34241907 Free PMC article. Review.
-
The old second messenger cAMP teams up with novel cell death mechanisms: potential translational therapeutical benefit for Alzheimer's disease and Parkinson's disease.Front Physiol. 2023 Jun 19;14:1207280. doi: 10.3389/fphys.2023.1207280. eCollection 2023. Front Physiol. 2023. PMID: 37405135 Free PMC article. Review.
-
The gliadin peptide 31-43 exacerbates kainate neurotoxicity in epilepsy models.Sci Rep. 2017 Nov 9;7(1):15146. doi: 10.1038/s41598-017-14845-4. Sci Rep. 2017. PMID: 29123180 Free PMC article.
-
Glutamate Receptor-Mediated Neurotoxicity in a Model of Ethanol Dependence and Withdrawal in Rat Organotypic Hippocampal Slice Cultures.Front Neurosci. 2019 Jan 24;12:1053. doi: 10.3389/fnins.2018.01053. eCollection 2018. Front Neurosci. 2019. PMID: 30733663 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous